Tolero Pharmaceuticals Home
Making Meaningful Medicines
Tolero Pharmaceuticals, Inc.,
a clinical-stage company, is developing treatments to improve and extend the lives of patients with serious hematological diseases.
clear space
Tolero Pharmaceuticals to Present Alvocidib Data at the 2015 American Society of Clinical Oncology... Line Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy of Alvocidib and Bromodomain Protein Inhibitors... Line Tolero Pharmaceuticals to Present at the American Association for Cancer Research 2015 Line Tolero Pharmaceuticals Receives EMA Orphan Drug Designation for Alvocidib...

Tolero Pharmaceuticals

Tolero PharmaceuticalsTolero Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to alleviating human suffering through the discovery and development of novel therapeutics to treat cancer and other serious human diseases. Our pipeline targets important biological drivers of blood disorders to treat leukemias and anemia. MORE
Learn how Tolero researchers are actively expanding scientific understanding of hematological disease. MORE
See how clinical trials on the use of Alvocidib to treat acute myeloid leukemia (AML) are demonstrating promising results. MORE
Find out how Tolero's pipeline agents offer tremendous opportunities for investors. MORE
clear space